共 91 条
Matrix metalloproteinases in tuberculosis
被引:102
作者:
Elkington, P. T.
[1
,2
]
Ugarte-Gil, C. A.
[1
,2
,3
]
Friedland, J. S.
[1
,2
]
机构:
[1] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London W12 0NN, England
[2] Imperial Coll Wellcome Trust Ctr Clin Trop Med, London, England
[3] Univ Peruana Cayetano Heredia, Lima, Peru
基金:
英国惠康基金;
英国医学研究理事会;
关键词:
Immunopathology;
lung;
matrix metalloproteinases;
tuberculosis;
NERVOUS-SYSTEM TUBERCULOSIS;
HUMAN MONOCYTIC CELLS;
NF-KAPPA-B;
MYCOBACTERIUM-TUBERCULOSIS;
PULMONARY TUBERCULOSIS;
MATRIX-METALLOPROTEINASE-9;
EXPRESSION;
GRANULOMA-FORMATION;
P38;
MAPK;
IN-VITRO;
CEREBROSPINAL-FLUID;
D O I:
10.1183/09031936.00015411
中图分类号:
R56 [呼吸系及胸部疾病];
学科分类号:
摘要:
Tuberculosis (TB) remains a global health pandemic. Infection is spread by the aerosol route and Mycobacterium tuberculosis must drive lung destruction to be transmitted to new hosts. Such inflammatory tissue damage is responsible for morbidity and mortality in patients. The underlying mechanisms of matrix destruction in TB remain poorly understood but consideration of the lung extracellular matrix predicts that matrix metalloproteinases (MMPs) will play a central role, owing to their unique ability to degrade fibrillar collagens and other matrix components. Since we proposed the concept of a matrix degrading phenotype in TB a decade ago, diverse data implicating MMPs as key mediators in TB pathology have accumulated. We review the lines of investigation that have indicated a critical role for MMPs in TB pathogenesis, consider regulatory pathways driving MMPs and propose that inhibition of MMP activity is a realistic goal as adjunctive therapy to limit immunopathology in TB.
引用
收藏
页码:456 / 464
页数:9
相关论文